-
1
-
-
78650156695
-
Diagnosis, treatment, and prognosis of glioma: Five new things
-
Taylor, L.P. Diagnosis, treatment, and prognosis of glioma: five new things. Neurology, 2010, 75, S28-32.
-
(2010)
Neurology
, vol.75
-
-
Taylor, L.P.1
-
2
-
-
78651423627
-
Experimental approaches for the treatment of malignant gliomas
-
Arko, L.; Katsyv, I.; Park, G.E.; Luan, W.P.; Park, J.K. Experimental approaches for the treatment of malignant gliomas. Pharmacol. Ther., 2010, 128, 1-36.
-
(2010)
Pharmacol. Ther.
, vol.128
, pp. 1-36
-
-
Arko, L.1
Katsyv, I.2
Park, G.E.3
Luan, W.P.4
Park, J.K.5
-
4
-
-
75149186046
-
Chemotherapy for glioblastoma: Current treatment and future perspectives for cytotoxic and targeted agents
-
Minniti, G.; Muni, R.; Lanzetta, G.; Marchetti, P.; Enrici, R.M. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res., 2009, 29, 5171-5184.
-
(2009)
Anticancer Res
, vol.29
, pp. 5171-5184
-
-
Minniti, G.1
Muni, R.2
Lanzetta, G.3
Marchetti, P.4
Enrici, R.M.5
-
5
-
-
79955825992
-
Temozolomide: Expanding its role in brain cancer
-
Mrugala, M.M.; Adair, J.; Kiem, H.P. Temozolomide: Expanding its role in brain cancer. Drugs Today (Barc), 2010, 46, 833-846.
-
(2010)
Drugs Today (Barc)
, vol.46
, pp. 833-846
-
-
Mrugala, M.M.1
Adair, J.2
Kiem, H.P.3
-
6
-
-
0035469483
-
Current and future developments in the use of temozolomide for the treatment of brain tumours
-
Stupp, R.; Gander, M.; Leyvraz, S.; Newlands, E. Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol., 2001, 2, 552-560.
-
(2001)
Lancet Oncol
, vol.2
, pp. 552-560
-
-
Stupp, R.1
Gander, M.2
Leyvraz, S.3
Newlands, E.4
-
7
-
-
49649104978
-
Mechanisms of chemoresistance to alkylating agents in malignant glioma
-
Sarkaria, J.N.; Kitange, G.J.; James, C.D.; Plummer, R.; Calvert, H.; Weller, M.; Wick, W. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin. Cancer Res., 2008, 14, 2900-2908.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 2900-2908
-
-
Sarkaria, J.N.1
Kitange, G.J.2
James, C.D.3
Plummer, R.4
Calvert, H.5
Weller, M.6
Wick, W.7
-
9
-
-
33644775576
-
Recent developments in the use of chemotherapy in brain tumours
-
van den Bent, M.J.; Hegi, M.E.; Stupp, R. Recent developments in the use of chemotherapy in brain tumours. Eur. J. Cancer, 2006, 42, 582-588.
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 582-588
-
-
van den Bent, M.J.1
Hegi, M.E.2
Stupp, R.3
-
10
-
-
35448967382
-
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas
-
Pyrko, P.; Schonthal, A.H.; Hofman, F.M.; Chen, T.C.; Lee, A.S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res, 2007, 67, 9809-9816.
-
(2007)
Cancer Res
, vol.67
, pp. 9809-9816
-
-
Pyrko, P.1
Schonthal, A.H.2
Hofman, F.M.3
Chen, T.C.4
Lee, A.S.5
-
11
-
-
33846674344
-
Integrated highresolution genome-wide analysis of gene dosage and gene expression in human brain tumors
-
Juric, D.; Bredel, C.; Sikic, B.I.; Bredel, M. Integrated highresolution genome-wide analysis of gene dosage and gene expression in human brain tumors. Methods Mol. Biol., 2007, 377, 187-202.
-
(2007)
Methods Mol. Biol.
, vol.377
, pp. 187-202
-
-
Juric, D.1
Bredel, C.2
Sikic, B.I.3
Bredel, M.4
-
12
-
-
74049085780
-
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches
-
Riemenschneider, M.J.; Reifenberger, G. Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches. Curr. Opin. Neurol., 2009, 22, 619-624.
-
(2009)
Curr. Opin. Neurol.
, vol.22
, pp. 619-624
-
-
Riemenschneider, M.J.1
Reifenberger, G.2
-
13
-
-
58149301357
-
Using gene expression profiling to identify a prognostic molecular spectrum in gliomas
-
Shirahata, M.; Oba, S.; Iwao-Koizumi, K.; Saito, S.; Ueno, N.; Oda, M.; Hashimoto, N.; Ishii, S.; Takahashi, J.A.; Kato, K. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas. Cancer Sci., 2009, 100, 165-172.
-
(2009)
Cancer Sci
, vol.100
, pp. 165-172
-
-
Shirahata, M.1
Oba, S.2
Iwao-Koizumi, K.3
Saito, S.4
Ueno, N.5
Oda, M.6
Hashimoto, N.7
Ishii, S.8
Takahashi, J.A.9
Kato, K.10
-
14
-
-
37049034871
-
Proteomic analysis of gliomas
-
Whittle, I.R.; Short, D.M.; Deighton, R.F.; Kerr, L.E.; Smith, C.; McCulloch, J. Proteomic analysis of gliomas. Br. J. Neurosurg., 2007, 21, 576-582.
-
(2007)
Br. J. Neurosurg.
, vol.21
, pp. 576-582
-
-
Whittle, I.R.1
Short, D.M.2
Deighton, R.F.3
Kerr, L.E.4
Smith, C.5
McCulloch, J.6
-
15
-
-
77956418572
-
Glioma proteomics: Status and perspectives
-
Niclou, S.P.; Fack, F.; Rajcevic, U. Glioma proteomics: status and perspectives. J. Proteom., 2010, 73, 1823-1838.
-
(2010)
J. Proteom.
, vol.73
, pp. 1823-1838
-
-
Niclou, S.P.1
Fack, F.2
Rajcevic, U.3
-
16
-
-
70350049244
-
Serum proteomics of glioma: Methods and applications
-
Somasundaram, K.; Nijaguna, M.B.; Kumar, D.M. Serum proteomics of glioma: methods and applications. Expert Rev. Mol. Diagn., 2009, 9, 695-707.
-
(2009)
Expert Rev. Mol. Diagn.
, vol.9
, pp. 695-707
-
-
Somasundaram, K.1
Nijaguna, M.B.2
Kumar, D.M.3
-
17
-
-
1942538346
-
Molecular classification and survival prediction in human gliomas based on proteome analysis
-
Iwadate, Y.; Sakaida, T.; Hiwasa, T.; Nagai, Y.; Ishikura, H.; Takiguchi, M.; Yamaura, A. Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res., 2004, 64, 2496-2501.
-
(2004)
Cancer Res
, vol.64
, pp. 2496-2501
-
-
Iwadate, Y.1
Sakaida, T.2
Hiwasa, T.3
Nagai, Y.4
Ishikura, H.5
Takiguchi, M.6
Yamaura, A.7
-
18
-
-
24744457360
-
Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry
-
Schwartz, S.A.; Weil, R.J.; Thompson, R.C.; Shyr, Y.; Moore, J.H.; Toms, S.A.; Johnson, M.D.; Caprioli, R.M. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res., 2005, 65, 7674-7681.
-
(2005)
Cancer Res
, vol.65
, pp. 7674-7681
-
-
Schwartz, S.A.1
Weil, R.J.2
Thompson, R.C.3
Shyr, Y.4
Moore, J.H.5
Toms, S.A.6
Johnson, M.D.7
Caprioli, R.M.8
-
19
-
-
77953222551
-
Glioma pathophysiology: Insights emerging from proteomics
-
Deighton, R.F.; McGregor, R.; Kemp, J.; McCulloch, J.; Whittle, I.R. Glioma pathophysiology: insights emerging from proteomics. Brain Pathol., 2010, 20, 691-703.
-
(2010)
Brain Pathol
, vol.20
, pp. 691-703
-
-
Deighton, R.F.1
McGregor, R.2
Kemp, J.3
McCulloch, J.4
Whittle, I.R.5
-
20
-
-
53749091148
-
Biomarkers of clinical responsiveness in brain tumor patients: Progress and potential
-
El-Jawahri, A.; Patel, D.; Zhang, M.; Mladkova, N.; Chakravarti, A. Biomarkers of clinical responsiveness in brain tumor patients: progress and potential. Mol. Diagn. Ther., 2008, 12, 199-208.
-
(2008)
Mol. Diagn. Ther.
, vol.12
, pp. 199-208
-
-
El-Jawahri, A.1
Patel, D.2
Zhang, M.3
Mladkova, N.4
Chakravarti, A.5
-
21
-
-
33845633819
-
Biomarker discovery: A proteomic approach for brain cancer profiling
-
Khalil, A.A. Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci., 2007, 98, 201-213.
-
(2007)
Cancer Sci
, vol.98
, pp. 201-213
-
-
Khalil, A.A.1
-
22
-
-
22844437186
-
Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas
-
Iwadate, Y.; Sakaida, T.; Saegusa, T.; Hiwasa, T.; Takiguchi, M.; Fujimoto, S.; Yamaura, A. Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas. Int. J. Oncol., 2005, 26, 993-998.
-
(2005)
Int. J. Oncol.
, vol.26
, pp. 993-998
-
-
Iwadate, Y.1
Sakaida, T.2
Saegusa, T.3
Hiwasa, T.4
Takiguchi, M.5
Fujimoto, S.6
Yamaura, A.7
-
23
-
-
34548218234
-
Proteomic comparison of oligodendrogliomas with and without 1pLOH
-
Okamoto, H.; Li, J.; Glasker, S.; Vortmeyer, A.O.; Jaffe, H.; Robison, R.A.; Bogler, O.; Mikkelsen, T.; Lubensky, I.A.; Oldfield, E.H.; Zhuang, Z. Proteomic comparison of oligodendrogliomas with and without 1pLOH. Cancer Biol. Ther., 2007, 6, 391-396.
-
(2007)
Cancer Biol. Ther.
, vol.6
, pp. 391-396
-
-
Okamoto, H.1
Li, J.2
Glasker, S.3
Vortmeyer, A.O.4
Jaffe, H.5
Robison, R.A.6
Bogler, O.7
Mikkelsen, T.8
Lubensky, I.A.9
Oldfield, E.H.10
Zhuang, Z.11
-
24
-
-
77952053290
-
Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion
-
Rostomily, R.C.; Born, D.E.; Beyer, R.P.; Jin, J.; Alvord, E.C., Jr.; Mikheev, A.M.; Matthews, R.T.; Pan, C.; Khorasani, L.; Sonnen, J.A.; Montine, T.J.; Shi, M.; Zhang, J. Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion. J. Proteome Res., 2010, 9, 2610-2618.
-
(2010)
J. Proteome Res.
, vol.9
, pp. 2610-2618
-
-
Rostomily, R.C.1
Born, D.E.2
Beyer, R.P.3
Jin, J.4
Alvord Jr., E.C.5
Mikheev, A.M.6
Matthews, R.T.7
Pan, C.8
Khorasani, L.9
Sonnen, J.A.10
Montine, T.J.11
Shi, M.12
Zhang, J.13
-
25
-
-
31644445293
-
Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles
-
Billecke, C.; Malik, I.; Movsisyan, A.; Sulghani, S.; Sharif, A.; Mikkelsen, T.; Farrell, N.P.; Bogler, O. Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles. Mol. Cell Proteom., 2006, 5, 35-42.
-
(2006)
Mol. Cell Proteom.
, vol.5
, pp. 35-42
-
-
Billecke, C.1
Malik, I.2
Movsisyan, A.3
Sulghani, S.4
Sharif, A.5
Mikkelsen, T.6
Farrell, N.P.7
Bogler, O.8
-
26
-
-
63049126568
-
Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes
-
Koncarevic, S.; Urig, S.; Steiner, K.; Rahlfs, S.; Herold-Mende, C.; Sueltmann, H.; Becker, K. Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes. Free Radic. Biol. Med., 2009, 46, 1096-1108.
-
(2009)
Free Radic. Biol. Med.
, vol.46
, pp. 1096-1108
-
-
Koncarevic, S.1
Urig, S.2
Steiner, K.3
Rahlfs, S.4
Herold-Mende, C.5
Sueltmann, H.6
Becker, K.7
-
27
-
-
21044434153
-
Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme
-
Vogel, T.W.; Zhuang, Z.; Li, J.; Okamoto, H.; Furuta, M.; Lee, Y.S.; Zeng, W.; Oldfield, E.H.; Vortmeyer, A.O.; Weil, R.J. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme. Clin. Cancer Res., 2005, 11, 3624-3632.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 3624-3632
-
-
Vogel, T.W.1
Zhuang, Z.2
Li, J.3
Okamoto, H.4
Furuta, M.5
Lee, Y.S.6
Zeng, W.7
Oldfield, E.H.8
Vortmeyer, A.O.9
Weil, R.J.10
-
28
-
-
0038326942
-
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors
-
Zhang, R.; Tremblay, T.L.; McDermid, A.; Thibault, P.; Stanimirovic, D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia, 2003, 42, 194-208.
-
(2003)
Glia
, vol.42
, pp. 194-208
-
-
Zhang, R.1
Tremblay, T.L.2
McDermid, A.3
Thibault, P.4
Stanimirovic, D.5
-
29
-
-
0028146767
-
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
-
Nishikawa, R.; Ji, X.D.; Harmon, R.C.; Lazar, C.S.; Gill, G.N.; Cavenee, W.K.; Huang, H.J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl.Acad. Sci. U. S. A., 1994, 91, 7727-7731.
-
(1994)
Proc. Natl.Acad. Sci. U. S. A.
, vol.91
, pp. 7727-7731
-
-
Nishikawa, R.1
Ji, X.D.2
Harmon, R.C.3
Lazar, C.S.4
Gill, G.N.5
Cavenee, W.K.6
Huang, H.J.7
-
30
-
-
4644309390
-
Protein patterns and proteins that identify subtypes of glioblastoma multiforme
-
Furuta, M.; Weil, R.J.; Vortmeyer, A.O.; Huang, S.; Lei, J.; Huang, T.N.; Lee, Y.S.; Bhowmick, D.A.; Lubensky, I.A.; Oldfield, E.H.; Zhuang, Z. Protein patterns and proteins that identify subtypes of glioblastoma multiforme. Oncogene, 2004, 23, 6806-6814.
-
(2004)
Oncogene
, vol.23
, pp. 6806-6814
-
-
Furuta, M.1
Weil, R.J.2
Vortmeyer, A.O.3
Huang, S.4
Lei, J.5
Huang, T.N.6
Lee, Y.S.7
Bhowmick, D.A.8
Lubensky, I.A.9
Oldfield, E.H.10
Zhuang, Z.11
-
31
-
-
33645867696
-
Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers
-
Li, J.; Zhuang, Z.; Okamoto, H.; Vortmeyer, A.O.; Park, D.M.; Furuta, M.; Lee, Y.S.; Oldfield, E.H.; Zeng, W.; Weil, R.J. Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers. Neurology, 2006, 66, 733-736.
-
(2006)
Neurology
, vol.66
, pp. 733-736
-
-
Li, J.1
Zhuang, Z.2
Okamoto, H.3
Vortmeyer, A.O.4
Park, D.M.5
Furuta, M.6
Lee, Y.S.7
Oldfield, E.H.8
Zeng, W.9
Weil, R.J.10
-
32
-
-
33748056466
-
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas
-
Fruehauf, J.P.; Brem, H.; Brem, S.; Sloan, A.; Barger, G.; Huang, W.; Parker, R. In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin. Cancer Res., 2006, 12, 4523-4532.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 4523-4532
-
-
Fruehauf, J.P.1
Brem, H.2
Brem, S.3
Sloan, A.4
Barger, G.5
Huang, W.6
Parker, R.7
-
33
-
-
20544461924
-
Use of proteomics to study chemosensitivity
-
Poland, J.; Wandschneider, S.; Urbani, A.; Bernardini, S.; Federici, G.; Sinha, P. Use of proteomics to study chemosensitivity. Methods Mol. Med., 2005, 111, 267-281.
-
(2005)
Methods Mol. Med.
, vol.111
, pp. 267-281
-
-
Poland, J.1
Wandschneider, S.2
Urbani, A.3
Bernardini, S.4
Federici, G.5
Sinha, P.6
-
34
-
-
0242695141
-
Study of the development of chemoresistance in melanoma cell lines using proteome analysis
-
Sinha, P.; Poland, J.; Kohl, S.; Schnolzer, M.; Helmbach, H.; Hutter, G.; Lage, H.; Schadendorf, D. Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis, 2003, 24, 2386-2404.
-
(2003)
Electrophoresis
, vol.24
, pp. 2386-2404
-
-
Sinha, P.1
Poland, J.2
Kohl, S.3
Schnolzer, M.4
Helmbach, H.5
Hutter, G.6
Lage, H.7
Schadendorf, D.8
-
35
-
-
1042303620
-
Study of the development of thermoresistance in human pancreatic carcinoma cell lines using proteome analysis
-
Poland, J.; Urbani, A.; Lage, H.; Schnolzer, M.; Sinha, P. Study of the development of thermoresistance in human pancreatic carcinoma cell lines using proteome analysis. Electrophoresis, 2004, 25, 173-183.
-
(2004)
Electrophoresis
, vol.25
, pp. 173-183
-
-
Poland, J.1
Urbani, A.2
Lage, H.3
Schnolzer, M.4
Sinha, P.5
-
36
-
-
34447259106
-
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs
-
Chuthapisith, S.; Layfield, R.; Kerr, I.D.; Hughes, C.; Eremin, O. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int. J. Oncol., 2007, 30, 1545-1551.
-
(2007)
Int. J. Oncol.
, vol.30
, pp. 1545-1551
-
-
Chuthapisith, S.1
Layfield, R.2
Kerr, I.D.3
Hughes, C.4
Eremin, O.5
-
37
-
-
33645469689
-
Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR
-
Yang, Y.X.; Xiao, Z.Q.; Chen, Z.C.; Zhang, G.Y.; Yi, H.; Zhang, P.F.; Li, J.L.; Zhu, G. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics, 2006, 6, 2009-2021.
-
(2006)
Proteomics
, vol.6
, pp. 2009-2021
-
-
Yang, Y.X.1
Xiao, Z.Q.2
Chen, Z.C.3
Zhang, G.Y.4
Yi, H.5
Zhang, P.F.6
Li, J.L.7
Zhu, G.8
-
38
-
-
70350786955
-
Downregulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells
-
Zheng, L.T.; Lee, S.; Yin, G.N.; Mori, K.; Suk, K. Downregulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells. J. Neurochem., 2009, 111, 1238-1251.
-
(2009)
J. Neurochem.
, vol.111
, pp. 1238-1251
-
-
Zheng, L.T.1
Lee, S.2
Yin, G.N.3
Mori, K.4
Suk, K.5
-
39
-
-
79954414405
-
Pro-apoptotic role of integrin beta3 in glioma cells
-
Epub a head of print
-
Kim, J.H.; Zheng, L.T.; Lee, W.H.; Suk, K. Pro-apoptotic role of integrin beta3 in glioma cells. J. Neurochem., 2011 [Epub a head of print].
-
(2011)
J. Neurochem.
-
-
Kim, J.H.1
Zheng, L.T.2
Lee, W.H.3
Suk, K.4
-
40
-
-
34248562291
-
Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death
-
Choi, K.J.; Piao, Y.J.; Lim, M.J.; Kim, J.H.; Ha, J.; Choe, W.; Kim, S.S. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Res., 2007, 67, 3654-3662.
-
(2007)
Cancer Res
, vol.67
, pp. 3654-3662
-
-
Choi, K.J.1
Piao, Y.J.2
Lim, M.J.3
Kim, J.H.4
Ha, J.5
Choe, W.6
Kim, S.S.7
-
41
-
-
59149102173
-
Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress
-
Kim, J.; Choi, T.G.; Ding, Y.; Kim, Y.; Ha, K.S.; Lee, K.H.; Kang, I.; Ha, J.; Kaufman, R.J.; Lee, J.; Choe, W.; Kim, S.S. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J. Cell Sci., 2008, 121, 3636-3648.
-
(2008)
J. Cell Sci.
, vol.121
, pp. 3636-3648
-
-
Kim, J.1
Choi, T.G.2
Ding, Y.3
Kim, Y.4
Ha, K.S.5
Lee, K.H.6
Kang, I.7
Ha, J.8
Kaufman, R.J.9
Lee, J.10
Choe, W.11
Kim, S.S.12
-
42
-
-
77952830627
-
Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells
-
Pucer, A.; Castino, R.; Mirkovic, B.; Falnoga, I.; Slejkovec, Z.; Isidoro, C.; Lah, T.T. Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells. Biol. Chem., 2010, 391, 519-531.
-
(2010)
Biol. Chem.
, vol.391
, pp. 519-531
-
-
Pucer, A.1
Castino, R.2
Mirkovic, B.3
Falnoga, I.4
Slejkovec, Z.5
Isidoro, C.6
Lah, T.T.7
-
43
-
-
0029908908
-
Secretion of protease nexin-1 by C6 glioma cells is under the control of a heterotrimeric G protein, Go1
-
Lagriffoul, A.; Charpentier, N.; Carrette, J.; Tougard, C.; Bockaert, J.; Homburger, V. Secretion of protease nexin-1 by C6 glioma cells is under the control of a heterotrimeric G protein, Go1. J. Biol. Chem., 1996, 271, 31508-31516.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 31508-31516
-
-
Lagriffoul, A.1
Charpentier, N.2
Carrette, J.3
Tougard, C.4
Bockaert, J.5
Homburger, V.6
-
44
-
-
70449519966
-
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation
-
Chiu, W.T.; Shen, S.C.; Chow, J.M.; Lin, C.W.; Shia, L.T.; Chen, Y.C. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation. Neurobiol. Dis., 2010, 37, 118-129.
-
(2010)
Neurobiol. Dis.
, vol.37
, pp. 118-129
-
-
Chiu, W.T.1
Shen, S.C.2
Chow, J.M.3
Lin, C.W.4
Shia, L.T.5
Chen, Y.C.6
-
45
-
-
0036826902
-
Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase
-
Stewart, V.C.; Stone, R.; Gegg, M.E.; Sharpe, M.A.; Hurst, R.D.; Clark, J.B.; Heales, S.J. Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J. Neurochem., 2002, 83, 984-991.
-
(2002)
J. Neurochem.
, vol.83
, pp. 984-991
-
-
Stewart, V.C.1
Stone, R.2
Gegg, M.E.3
Sharpe, M.A.4
Hurst, R.D.5
Clark, J.B.6
Heales, S.J.7
-
46
-
-
70350449049
-
Mass spectrometry-based clinical proteomics profiling: Current status and future directions
-
Findeisen, P.; Neumaier, M. Mass spectrometry-based clinical proteomics profiling: current status and future directions. Expert Rev. Proteom., 2009, 6, 457-459.
-
(2009)
Expert Rev. Proteom.
, vol.6
, pp. 457-459
-
-
Findeisen, P.1
Neumaier, M.2
-
47
-
-
33646947821
-
Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein
-
Borregaard, N.; Cowland, J.B. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals, 2006, 19, 211-215.
-
(2006)
Biometals
, vol.19
, pp. 211-215
-
-
Borregaard, N.1
Cowland, J.B.2
-
48
-
-
77952243719
-
Lipocalin-2: Pro- or anti-apoptotic?
-
Kehrer, J.P. Lipocalin-2: pro- or anti-apoptotic? Cell Biol. Toxicol., 2010, 26, 83-89.
-
(2010)
Cell Biol. Toxicol.
, vol.26
, pp. 83-89
-
-
Kehrer, J.P.1
-
49
-
-
29244457829
-
24p3 and its receptor: Dawn of a new iron age?
-
Richardson
-
Richardson, D.R. 24p3 and its receptor: dawn of a new iron age? Cell, 2005, 123, 1175-1177.
-
(2005)
Cell
, vol.123
, pp. 1175-1177
-
-
Richardson, D.R.1
-
50
-
-
33846682720
-
Dual action of neutrophil gelatinaseassociated lipocalin
-
Schmidt-Ott, K.M.; Mori, K.; Li, J.Y.; Kalandadze, A.; Cohen, D.J.; Devarajan, P.; Barasch, J. Dual action of neutrophil gelatinaseassociated lipocalin. J. Am. Soc. Nephrol., 2007, 18, 407-413.
-
(2007)
J. Am. Soc. Nephrol.
, vol.18
, pp. 407-413
-
-
Schmidt-Ott, K.M.1
Mori, K.2
Li, J.Y.3
Kalandadze, A.4
Cohen, D.J.5
Devarajan, P.6
Barasch, J.7
-
51
-
-
78649641929
-
Relationships of lipocalin 2 with breast tumorigenesis and metastasis
-
Leng, X.; Wu, Y.; Arlinghaus, R.B. Relationships of lipocalin 2 with breast tumorigenesis and metastasis. J. Cell Physiol., 2011, 226, 309-314.
-
(2011)
J. Cell Physiol.
, vol.226
, pp. 309-314
-
-
Leng, X.1
Wu, Y.2
Arlinghaus, R.B.3
-
52
-
-
0037145037
-
Integrins: Bidirectional, allosteric signaling machines
-
Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell, 2002, 110, 673-687.
-
(2002)
Cell
, vol.110
, pp. 673-687
-
-
Hynes, R.O.1
-
53
-
-
34548826824
-
The integrins
-
Takada, Y.; Ye, X.; Simon, S. The integrins. Genome Biol., 2007, 8, 215.
-
(2007)
Genome Biol
, vol.8
, pp. 215
-
-
Takada, Y.1
Ye, X.2
Simon, S.3
-
54
-
-
0036829759
-
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model
-
Janssen, M.L.; Oyen, W.J.; Dijkgraaf, I.; Massuger, L.F.; Frielink, C.; Edwards, D.S.; Rajopadhye, M.; Boonstra, H.; Corstens, F.H.; Boerman, O.C. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Cancer Res., 2002, 62, 6146-6151.
-
(2002)
Cancer Res
, vol.62
, pp. 6146-6151
-
-
Janssen, M.L.1
Oyen, W.J.2
Dijkgraaf, I.3
Massuger, L.F.4
Frielink, C.5
Edwards, D.S.6
Rajopadhye, M.7
Boonstra, H.8
Corstens, F.H.9
Boerman, O.C.10
-
55
-
-
34548680519
-
Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling
-
McCabe, N.P.; De, S.; Vasanji, A.; Brainard, J.; Byzova, T.V. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene, 2007, 26, 6238-6243.
-
(2007)
Oncogene
, vol.26
, pp. 6238-6243
-
-
McCabe, N.P.1
De, S.2
Vasanji, A.3
Brainard, J.4
Byzova, T.V.5
-
56
-
-
49649122544
-
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling
-
Mori, S.; Wu, C.Y.; Yamaji, S.; Saegusa, J.; Shi, B.; Ma, Z.; Kuwabara, Y.; Lam, K.S.; Isseroff, R.R.; Takada, Y.K.; Takada, Y. Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling. J. Biol. Chem., 2008, 283, 18066-18075.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 18066-18075
-
-
Mori, S.1
Wu, C.Y.2
Yamaji, S.3
Saegusa, J.4
Shi, B.5
Ma, Z.6
Kuwabara, Y.7
Lam, K.S.8
Isseroff, R.R.9
Takada, Y.K.10
Takada, Y.11
-
57
-
-
0029610677
-
Definition of two angiogenic pathways by distinct alpha v integrins
-
Friedlander, M.; Brooks, P.C.; Shaffer, R.W.; Kincaid, C.M.; Varner, J.A.; Cheresh, D.A. Definition of two angiogenic pathways by distinct alpha v integrins. Science, 1995, 270, 1500-1502.
-
(1995)
Science
, vol.270
, pp. 1500-1502
-
-
Friedlander, M.1
Brooks, P.C.2
Shaffer, R.W.3
Kincaid, C.M.4
Varner, J.A.5
Cheresh, D.A.6
|